The immune modulatory effects of prolactin and cortisol in Hashimotos thyroiditis – A case control study
Paper Details
The immune modulatory effects of prolactin and cortisol in Hashimotos thyroiditis – A case control study
Abstract
The immune modulatory effect of serum prolactin (PRL) and cortisol were studied in Hashimoto’s thyroiditis (HT). The present case control study was conducted at the Department of Endocrinology, Institute of nuclear medicine and radiotherapy, Peshawar, Khyber-Pakhtunkhwa, Pakistan, from January 2017 to December 2017. Forty eight HT patients including (29 females) (34.97±1.454 years) and (19 males) (38.42±1.805 years) were selected. The thirty six control subjects included 21 females (31.43±1.698 years) and 15 males (37.93±2.561 years). HT females showed significantly higher (p = 0.0396) PRL values (631.8±119.7 mIU/L) than the control (322.7±44.84 mIU/L). Similarly HT males showed increased PRL values (p= 0.0215) (466.3±120.6 mIU/L) than control (134.4±19.59 mIU/L). In contrast, cortisol level was low in all HT patients (female= 101.9±20.37 ng/ml) and (male=106.8±21.77 ng/ml). Cortisol level in control females and males were (123±15.45 ng/ml.) and (163.9±23.25ng/ml) respectively. The TSH level was high in both males (16.24±1.135µIU/L) and females (5.793±1.395 µIU/L) patients while in control it was between the normal ranges (05-5µIU/L). The TT4 values in HT females (16.45±0.848 nmol/L) and males (6.956±2.667 nmol/L) were significantly lower than control. In conclusion, our results provide evidence for an altered prolactin-cortisol status in Hashimoto’s thyroiditis patients.
Agha-Hosseini F, Shirzad N, Moosavi MS. 2016. The association of elevated plasma cortisol and Hashimoto’s Thyroiditis, a neglected part of immune response. Acta Clinica Belgica 71(2), 81-85.
Coronel-Restrepo N, Posso-Osorio I, Naranjo-Escobar J, Tobón GJ. 2017. Autoimmune diseases and their relation with immunological, neurological and endocrinological axes. Autoimmunity reviews 16(7), 684-692.
Costanza M, Binart N, Steinman L, Pedotti R. 2015. Prolactin: a versatile regulator of inflammation and autoimmune pathology. Autoimmunity reviews 14(3), 223-230.
da Rosa Franchi Santos LF, Stadtlober NP, Costa Dall’Aqua LG, Scavuzzi BM, Guimarães PM, Flauzino T, Maes, M. 2018. Increased adhesion molecule levels in systemic lupus erythematosus: relationships with severity of illness, autoimmunity, and metabolic syndrome and cortisol levels. Lupus 27(3), 380-388.
Dogansen SC, Selcukbiricik OS, Bilir BE, Yarman S. 2016. The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas. Growth Hormone & IGF Research 29, 45-49.
Elenkova A, Petrossians P, Zacharieva S, Beckers A. 2016. High prevalence of autoimmune thyroid diseases in patients with prolactinomas: a cross-sectional retrospective study in a single tertiary referral center. Annales d’endocrinologie 77(1), 37-42.
Karimifar M, Tahmasebi A, Bonakdar ZS, Purajam S. 2013. Correlation of serum prolactin levels and disease activity in systematic lupus erythematosus. Rheumatology international 33, 511-6.
Khan Q, Zahid M, Rasool M, Khayyam K, Ismail MK, Haq UM, Jawad MS. 2018. Serum prolactin and reproductive hormones in female autoimmune thyroid patients-a case-control study. Jukoll journal 68(3), 43-53.
Klecha AJ, Arcos MLB, Frick L, Genaro AM, Cremaschi G. 2008. Immune-endocrine interactions in autoimmune thyroid diseases. Neuroimmunomodulation 15(1), 68-75.
Lajevardi V, Hallaji Z, Daneshpazhooh M, Ghandi N, Shekari P, Khani S. 2016. Evaluation of prolactin levels in patients with newly diagnosed pemphigus vulgaris and its correlation with pemphigus disease area index. International Journal of Women’s Dermatology 2, 53-5.
Legakis I, Petroyianni V, Saramantis A, Tolis G. 2001. Elevated prolactin to cortisol ratio and polyclonal autoimmune activation in Hashimoto’s thyroiditis. Hormone and Metabolic Research 33(10), 585-589.
Moszkorzova L, Lacinova Z, Marek J, Musilova L, Dohnalova A, Dostal C. 2002. Hyperprolactinaemia in patients with systemic lupus erythematosus. Clinical and experimental rheumatology 20(6), 807-812.
Neidhart M. 1996. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. The Journal of rheumatology 23(3), 476-481.
Onal ED, Saglam F, Sacikara M, Ersoy R, Cakir B. 2014. Thyroid autoimmunity in patients with hyperprolactinemia: an observational study. Arquivos Brasileiros de Endocrinologia & Metabologia 58(1), 48-52.
Orbach H, Shoenfeld Y. 2007. Hyperprolactinemia and autoimmune diseases. Autoimmunity reviews 6(8), 537-542.
Orbach H, Zandman‐goddard GISELE, Amital H, Barak V, Szekanecz Z, Szucs G, Doria A. 2007. Novel biomarkers in autoimmune diseases. Annals of the New York Academy of Sciences 1109(1), 385-400.
Poyraz BÇ, Aksoy C, Balcıoğlu İ. 2008. Increased incidence of autoimmune thyroiditis in patients with antipsychotic- induced hyperprolactinemia. European Neuropsy chophar macology 18(9), 667-672.
Savino W. 2017. Prolactin: an immunomodulator in health and disease. In Endocrine Immunology 48, 69-75.
Sayki Arslan M, Sahin M, Topaloglu O, Tutal E, Karakose M, Gungunes A, Cakal E, Ozbek M, Delibasi T. 2013. Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma. Clinical endocrinology 79, 882-6.
Shelly S, Boaz M, Orbach H. 2012. Prolactin and autoimmunity. Autoimmunity reviews 11(6-7), A465-A470.
Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, Carvalho JD. 2008. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases. The Israel Medical Association Journal 10(1), 8.
Walter KN, Corwin EJ, Ulbrecht J, Demers LM, Bennett JM, Whetzel CA, Klein, LC. 2012. Elevated thyroid stimulating hormone is associated with elevated cortisol in healthy young men and women. Thyroid research 5(1), 13.
Wei W, Liu L, Cheng ZL, Hu B. 2017. Increased plasma/serum levels of prolactin in multiple sclerosis: a meta-analysis. Postgraduate medicine 129(6), 605-610.
Zoli A, Lizzio MM, Ferlisi EM, Massafra V, Mirone L, Barini A, Magaro M. 2002. ACTH, cortisol and prolactin in active rheumatoid arthritis. Clinical rheumatology 21(4), 289-293.
Khayyam, Muhammad Zahid, Naiz Ali, Qadeem khan, 2018. The immune modulatory effects of prolactin and cortisol in Hashimotos thyroiditis – A case control study. Int. J. Biosci., 13(2), 133-139.
Copyright © 2018 by the Authors. This article is an open access article and distributed under the terms and conditions of the Creative Commons Attribution 4.0 (CC BY 4.0) license.